Company Filing History:
Years Active: 2008-2013
Title: Moiz Kitabwalla: Innovator in Vaccine Development
Introduction
Moiz Kitabwalla is a prominent inventor based in Livermore, California, known for his significant contributions to the field of vaccine development. With a total of four patents to his name, he has focused on creating innovative solutions to combat infectious diseases and cancer.
Latest Patents
One of his latest patents involves SARS vaccine compositions and methods of making and using them. This invention describes a composition and method aimed at reducing the occurrence and severity of infectious diseases, particularly those caused by lipid-containing infectious viral organisms found in biological fluids like blood. The invention utilizes solvents to extract lipids from these viral organisms, resulting in immunogenic modified, partially delipidated viral particles with reduced infectivity. These vaccine compositions can be administered to patients to provide protection against such infections or to treat existing infections.
Another notable patent by Kitabwalla focuses on a method of treating cancer cells to create modified cancer cell particles that provoke an immunogenic response. This delipidation method employs a solvent system to extract lipids from cancer cells while preserving a portion of the cancer cell antigens. The resulting modified cancer cell particles can initiate a positive immunogenic response when administered, aiding in the treatment, prevention, or delay of cancer onset.
Career Highlights
Throughout his career, Moiz Kitabwalla has worked with notable companies such as Eli Lilly and Company and Lipid Sciences, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and vaccine development.
Collaborations
One of his notable collaborators is Hassibullah Akeefe, with whom he has worked on various projects related to his patents and innovations.
Conclusion
Moiz Kitabwalla's work in vaccine development showcases his commitment to addressing critical health challenges through innovative solutions. His patents reflect a deep understanding of infectious diseases and cancer treatment, positioning him as a key figure in the field of biotechnology.